Exploring Predictors of Hypertension Development With Pazopanib and Examining Predictive Performance Over Time

Area of Science:

• Oncology
• Pharmacology
• Cardiovascular Medicine

Background:

• Pazopanib treatment is frequently associated with hypertension.
• Identifying predictive factors for this adverse event is crucial for patient management.

Purpose of the Study:

• To identify predictors of pazopanib-induced hypertension.
• To evaluate the temporal predictive performance of identified factors.

Main Methods:

• Logistic regression analysis of patient background factors.
• Time-dependent receiver operating characteristic (ROC) analysis to assess predictive performance over time.
• Study included 47 patients treated with pazopanib for renal cell carcinoma or soft tissue sarcoma.

Main Results:

• Total bilirubin (t-bil), sex, and pre-treatment systolic blood pressure (SBP) were identified as predictors.
• Time-dependent ROC analysis indicated SBP was a stronger predictor in the early treatment phase, while t-bil was more predictive later.
• Combined models (SBP+t-bil, SBP+t-bil+sex) demonstrated sustained predictive accuracy throughout the treatment period.

Conclusions:

• Total bilirubin and sex are significant predictors of pazopanib-induced hypertension.
• Total bilirubin shows potential for predicting hypertension development from day 5 onwards.
• These factors can aid in early risk stratification and management of pazopanib-treated patients.